A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age - MI-CP185

Study identifier:MI-CP185

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Randomized, Double-Blind, Active Controlled Study to Evaluate the Immunogenicity of MEDI3250 in Adults 18 to 49 Years of Age

Medical condition

healthy or stable underlying chronic medical condition

Phase

Phase 2/3

Healthy volunteers

Yes

Study drug

-

Sex

All

Actual Enrollment

1800

Study type

Interventional

Age

18 Years - 49 Years

Date

Study Start Date: 01 Mar 2009
Primary Completion Date: 01 May 2009
Study Completion Date: 01 Oct 2009

Study design

Allocation: Randomized
Endpoint Classification: Bio-equivalence Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Prevention

Verification:

Verified 01 Nov 2011 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

-

Inclusion and exclusion criteria